Sebastian Seget
Overview
Explore the profile of Sebastian Seget including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klenczar-Kciuk K, Seget S, Adamczyk P, Jarosz-Chobot P
Endokrynol Pol
. 2025 Mar;
76(1):59-65.
PMID: 40071800
Introduction: In recent years, the prevalence of T1DM (type 1 diabetes mellitus) and other autoimmune diseases in the paediatric population has been increasing. The aim of this study was to...
2.
Stadnik J, Seget S, Tarasiewicz M, Jarosz-Chobot P, Piatek K, Drozdz M, et al.
J Diabetes Investig
. 2024 Dec;
PMID: 39665255
With the rapid advancement of diabetes technology, the number of patients with type 1 diabetes (T1D) using automated insulin delivery (AID) systems is increasing, making the presence of such patients...
3.
Tarasiewicz M, Pietrzykowska A, Wlodarczyk J, Seget S, Gadzalska K, Jakiel P, et al.
Healthcare (Basel)
. 2024 Jul;
12(13).
PMID: 38998792
Transient neonatal diabetes mellitus (TNDM) is a genetically heterogeneous form of neonatal diabetes characterized by hyperglycemia that remits during infancy with a tendency to recur in later life. This case...
4.
Seget S, Chobot A, Tarasiewicz M, Bielawska A, Rusak E, Ochab A, et al.
Front Endocrinol (Lausanne)
. 2024 Feb;
15:1332418.
PMID: 38390211
Background And Aims: MiniMed 780G is the first Advanced Hybrid Closed Loop (AHCL) system in Poland, approved in the EU in 2020. To date, observations of glycemic control up to...
5.
Seget S, Chobot A, Rusak E, Ochab A, Bielawska A, Polanska J, et al.
Technol Health Care
. 2023 Oct;
32(3):1463-1472.
PMID: 37781828
Background: Given the steadily rising incidence of type 1 diabetes (T1D), particularly among the youngest preschool children, coupled with well-documented challenges of achieving and maintaining optimal metabolic control in this...
6.
Seget S, Tekielak A, Rusak E, Jarosz-Chobot P
Pediatr Endocrinol Diabetes Metab
. 2023 May;
29(1):30-36.
PMID: 37218723
Technological advances offer the opportunity to improve glycemic control and reduce the risk of complications and burden of type 1 diabetes while improving patient quality of life. Closed-loop insulin delivery...
7.
Seget S, Wlodarczyk J, Lutogniewska W, Rusak E, Drozdz M, Jarosz-Chobot P
Healthcare (Basel)
. 2023 Feb;
11(4).
PMID: 36833120
Technological progress in the treatment of type 1 diabetes requires doctors to use modern methods of insulin therapy in all areas of medicine that patients may come into contact with,...
8.
Seget S, Jarosz-Chobot P, Ochab A, Polanska J, Rusak E, Witoszek P, et al.
Front Endocrinol (Lausanne)
. 2022 Oct;
13:1036808.
PMID: 36303875
Background: Information on the influence of insulin treatment using advanced hybrid closed loop systems (AHCL) on body weight of young patients with type 1 diabetes (T1D) is scarce. The aim...
9.
Vazeou A, Tittel S, Kordonouri O, Birkebaek N, Iotova V, Piccini B, et al.
Diabetes Obes Metab
. 2022 Sep;
24(12):2420-2430.
PMID: 36089908
Aims: To investigate the prevalence of modifiable cardiovascular risk factors (CVRFs), including dyslipidaemia, obesity and high glycated haemoglobin (HbA1c) concentration, in patients with type 1 diabetes (T1D), and to evaluate...
10.
Seget S, Rusak E, Polanska J, Jarosz-Chobot P
Diabetes Technol Ther
. 2022 Jul;
24(11):824-831.
PMID: 35852811
The aim of this prospective open-label single-arm single-center follow-up study was to analyze glycemic control in children and adolescents with type 1 diabetes treated with the advanced hybrid closed loop...